Why Forecasting in Medtech Is so Hard and What Can Be Done About It

Posted by Wenhao Xia on August 22, 2019

Sales forecasts play a critical role in the success of every company. An accurate and sufficiently granular forecast is critical for ongoing demand planning, brand strategy, investor communications, inventory and manufacturing, and many other core functions for any company.


>
Read More

Assessing the Future of Robotics in Medtech

Posted by Andy Kach on August 14, 2019

This article was originally published in Medtech Insight.

Every medical device company—in and out of the surgical business—and many other tech companies are deep in the war of surgical robotics and digital solutions.


>
Read More

AI in Medtech: Innovating in An Era of Uncertainty

Posted by Kate Templeton on July 23, 2019

This post is the second in a multi-part series on how the rules of the road are changing in medtech, and the implications on commercial strategy. Sundeep Karnik contributed to this blog post.

With the speed and impact of innovation increasing rapidly, our institutions have struggled to keep up. For better or worse, rules and regulations have typically lagged behind the innovation frontier, responding only when a crisis or particular incident highlights a new challenge to be managed or risk to be mitigated. This dynamic isn’t specific to healthcare—just think back on all of the questions raised in the last few years with Tesla’s autopilot car crashes to see the parallels. Regardless of industry, for those innovators on the cutting edge, this creates an environment of regulatory uncertainly that is inherently risky for the companies that blaze forward assuming a specific regulatory approach will be adopted by the relevant authorities. The more disruptive the technology, the more likely it is that such an environment will exist.


>
Read More

On the Road to Analytically Driven: Four Takeaways from Medtech Connect 2019

Posted by Bhargav Mantha on July 16, 2019

The medtech industry continues to face several headwinds. The buyer center is changing. Providers are consolidating. There’s an increased focus on value and business model disruption. Medtech faces some existential questions, forcing it to find new ways to stoke growth and stem profit erosion. Our stance has always been that, in addition to revamping its business strategy, medtech needs to become analytically-driven. Medtech companies must leverage their data and analytics to optimize their business strategies and enable growth in ways that are consistent, continuous and agile.


>
Read More

A Modern Approach to Portfolio Strategy: From Feature Innovation to Value Innovation

Posted by Matt Singer on June 21, 2019

Originally published on AdvaMed’s Medtech Conference blog.

In a recent ZS survey with hospital executives in the U.S. and Europe, we found that 90% of respondents think that medtech manufacturers can’t succeed with product innovation alone. Moreover, that same number of respondents said that they didn’t believe that medtech companies understand the trends shaping the healthcare landscape and how those trends affect providers—and, therefore, what medtech customers need and value.


>
Read More